Pancreatic Cancer: Related News

On Our Blog

Pictured: Kenneth Yu
Blood Test Could Predict Which Patients with Pancreatic Cancer May Benefit from Chemotherapy

New research suggests that analyzing genetic changes found in the bloodstream may help doctors predict which chemotherapy regimens will work for some patients.

January 29, 2013
Pictured: Michael D’Angelica
Meet Surgeon Michael D’Angelica

Dr. D’Angelica – who treats patients with liver, pancreatic, and bile duct cancers – discusses the expertise of Memorial Sloan-Kettering surgeons, who routinely perform complex procedures.

August 21, 2012

Related Media Coverage

Blood Test Might Help Guide Pancreatic Cancer Treatment

Medical oncologist Kenneth Yu spoke about a study he led that suggests that a simple blood test may be able to predict which chemotherapy regimen will work for some patients with pancreatic cancer.

HealthDay
January 22, 2013
Working to “Add to the Solution"

Memorial Sloan-Kettering Board member David M. Rubenstein spoke about his $10 million contribution to establish a new pancreatic cancer research center at the hospital, and Department of Surgery Vice Chair Ronald DeMatteo commented on the need for progress against the deadly disease.

The Wall Street Journal
December 7, 2012
The Puzzle of Pancreatic Cancer: How Steve Jobs Did Not Beat the Odds — but Nobel Winner Ralph Steinman Did

Despite having the same name, the diseases that killed Steve Jobs and 2011 Nobel Prize winner Ralph Steinman are two different kinds of cancer. Medical oncologist Leonard Saltz explains.

Scientific American
October 7, 2011

On Cancer

News and Insights from
Memorial Sloan-Kettering
Read Our Blog »

Center News

Pictured: Center News, April 2013
Read Our Magazine »

Subscribe to Our E-newsletter

Get the latest information about cancer care.